AUM Biosciences announces closing of $27 million in a “Series A” round of funding
This round was led by Singapore-based Everlife and SPRIM Global investments (SGI)
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.